| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.7% | 75.8% | ▼ -3.0% |
| Healthcare Services | 12.1% | 11.5% | ▼ -0.6% |
| Retailing | 5.6% | 5.4% | ▼ -0.3% |
| Chemicals & Petrochemicals | 1.2% | 1.3% | ▲ +0.1% |
| Insurance | 1.4% | 1.3% | ● -0.1% |
| Healthcare Equipment & Supplies | 0.8% | 0.8% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 75.8% | 76.2% | ▲ +0.5% |
| Healthcare Services | 11.5% | 12.2% | ▲ +0.7% |
| Retailing | 5.4% | 5.5% | ▲ +0.2% |
| Insurance | 1.3% | 1.3% | ● -0.1% |
| Chemicals & Petrochemicals | 1.3% | 1.2% | ▼ -0.2% |
| Healthcare Equipment & Supplies | 0.8% | 0.8% | ● 0.0% |
Comparing Jun 2026 → Jul 2026
| # | Stock | Sector | Weight (Jul 2026) |
|---|---|---|---|
| 1 | Manipal Health Enterprises Ltd ₹49.95 Cr |
Healthcare Services | 0.73% |
| 2 | Jupiter Life Line Hospitals Limited ₹31.67 Cr |
Healthcare Services | 0.47% |
| # | Stock | Sector | Last Weight (Jun 2026) |
|---|---|---|---|
| 1 | JB Chemicals & Pharmaceuticals Limited ₹103.27 Cr |
Pharmaceuticals & Biotechnology | 1.56% |
| 2 | Jupiter Life Line Hospitals Ltd ₹27.15 Cr |
Healthcare Services | 0.41% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Biocon Limited ₹338.14 Cr |
Pharmaceuticals & Biotechnology | 2.59% | 4.97% | +2.38% |
| 2 | AstraZeneca Pharma India Limited ₹126.21 Cr |
Pharmaceuticals & Biotechnology | 0.82% | 1.86% | +1.04% |
| 3 | Blue Jet Healthcare Ltd ₹162.70 Cr |
Pharmaceuticals & Biotechnology | 1.51% | 2.39% | +0.88% |
| 4 | Sun Pharmaceutical Industries Limited ₹863.50 Cr |
Pharmaceuticals & Biotechnology | 12.20% | 12.69% | +0.49% |
| 5 | Divi's Laboratories Limited ₹410.11 Cr |
Pharmaceuticals & Biotechnology | 5.57% | 6.03% | +0.46% |
| 6 | Syngene International Limited ₹221.81 Cr |
Healthcare Services | 2.89% | 3.26% | +0.37% |
| 7 | Dr. Reddy's Laboratories Limited ₹574.97 Cr |
Pharmaceuticals & Biotechnology | 8.22% | 8.45% | +0.23% |
| 8 | Abbott India Limited ₹178.92 Cr |
Pharmaceuticals & Biotechnology | 2.47% | 2.63% | +0.16% |
| 9 | MedPlus Health Services Limited ₹258.36 Cr |
Retailing | 3.66% | 3.80% | +0.14% |
| 10 | Pfizer Limited ₹133.86 Cr |
Pharmaceuticals & Biotechnology | 1.86% | 1.97% | +0.11% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Mankind Pharma Limited ₹372.19 Cr |
Pharmaceuticals & Biotechnology | 6.98% | 5.47% | -1.51% |
| 2 | Alkem Laboratories Limited ₹347.80 Cr |
Pharmaceuticals & Biotechnology | 5.67% | 5.11% | -0.56% |
| 3 | Cohance Lifesciences Limited ₹266.37 Cr |
Pharmaceuticals & Biotechnology | 4.31% | 3.92% | -0.39% |
| 4 | Aurobindo Pharma Limited ₹55.40 Cr |
Pharmaceuticals & Biotechnology | 1.17% | 0.81% | -0.36% |
| 5 | Max Healthcare Institute Limited ₹191.30 Cr |
Healthcare Services | 3.10% | 2.81% | -0.29% |
| 6 | Thyrocare Technologies Limited ₹132.39 Cr |
Healthcare Services | 2.24% | 1.95% | -0.29% |
| 7 | Alivus Life Sciences ₹90.40 Cr |
Pharmaceuticals & Biotechnology | 1.54% | 1.33% | -0.21% |
| 8 | Akums Drugs and Pharmaceuticals Limited ₹128.59 Cr |
Pharmaceuticals & Biotechnology | 2.05% | 1.89% | -0.16% |
| 9 | Hikal Limited ₹80.58 Cr |
Pharmaceuticals & Biotechnology | 1.34% | 1.18% | -0.16% |
| 10 | Alembic Pharmaceuticals Limited ₹165.58 Cr |
Pharmaceuticals & Biotechnology | 2.58% | 2.43% | -0.15% |
35 stocks — Jul 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹863.50 Cr |
Pharmaceuticals & Biotechnology |
12.69%
|
|
| 2 |
₹574.97 Cr |
Pharmaceuticals & Biotechnology |
8.45%
|
|
| 3 |
₹445.96 Cr |
Pharmaceuticals & Biotechnology |
6.56%
|
|
| 4 |
₹410.11 Cr |
Pharmaceuticals & Biotechnology |
6.03%
|
|
| 5 |
₹372.19 Cr |
Pharmaceuticals & Biotechnology |
5.47%
|
|
| 6 |
₹347.80 Cr |
Pharmaceuticals & Biotechnology |
5.11%
|
|
| 7 |
₹338.14 Cr |
Pharmaceuticals & Biotechnology |
4.97%
|
|
| 8 |
₹266.37 Cr |
Pharmaceuticals & Biotechnology |
3.92%
|
|
| 9 |
₹258.36 Cr |
Retailing |
3.80%
|
|
| 10 |
₹221.81 Cr |
Healthcare Services |
3.26%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.